Get A Free Legal Consultation
Since 1999, we've helped thousands of families across the country get compensation. Let us help you too.
- We fight to maximize your results
- No out-of-pocket costs
- Over $10.1 billion recovered for families
EzriCare® Eye Drops Lawsuit
Delsam Pharma® and EzriCare® Artificial Tears — over-the-counter eye drops for dry eyes — have recently been linked to various types of infections, including infections that may cause vision damage and blindness.
The Centers for Disease Control and Prevention (CDC) found the presence of a bacteria known as carbapenem-resistant Pseudomonas aeruginosa (CRPA) in Delsam’s and EzriCare’s lubricant eye drops.
If you developed an eye infection or experienced vision loss after using Delsam Pharma or EzriCare Artificial Tears, you may be able to pursue compensation from a lawsuit for your injuries. Contact us now to learn more.
September 2023 Update:
Delsam & EzriCare Artificial Tears Recalled
In February 2023, Global Pharma Healthcare — the manufacturer of Delsam and EzriCare Artificial Tears — issued a voluntary recall of their lubricating eye drops and ointment.
This recall came at the suggestion of the U.S. Food and Drug Administration (FDA) following a study conducted by the CDC. The study discovered the presence of a bacteria known as Pseudomonas aeruginosa in the eye drops. Unfortunately, this bacteria is resistant to carbapenem, an antibiotic used to treat complicated bacterial infections.
To date, the CDC has identified 68 people across 16 states with infections related to carbapenem-resistant Pseudomonas aeruginosa (CRPA) , and many patients reported using EzriCare’s Artificial Tears eye drops. Testing conducted in a laboratory on opened bottles of the eye drops identified the presence of CRPA.
Eye drops that may be contaminated with CRPA are labeled with the following product codes:
- Ezricare NDC 79503-0101-15, UPC 3 79503 10115 7
- Delsam Pharma’s NDC 72570-121-15, UPC 3 72570 12115 8
On February 22, the recall was expanded to include Delsam Pharma’s Artificial Eye Ointment out of fear of the same contamination issues.
Doctors and patients are urged to immediately halt the use of EzriCare’s eye drops and dispose of the product at this time.
What Is Carbapenem-Resistant Pseudomonas Aeruginosa?
Carbapenem-resistant Pseudomonas aeruginosa are bacteria that are resistant to carbapenem antibiotics and can cause infections throughout the body, like in the blood, lungs and eyes.
Pseudomonas can be found throughout the environment, including in water and dirt. Pseudomonas aeruginosa, a specific strain of this bacteria, may cause infections to develop within humans.
Eye infections related to CRPA can cause pain, vision loss or other infections.
Unfortunately, Pseudomonas aeruginosa can evolve and become resistant to antibiotics like carbapenem, making infections caused by this type of bacteria more difficult to treat.
Because CRPA infections have limited treatment options, it is important to contact your doctor as soon as possible if you believe your infection was caused by this bacteria.
Symptoms of CRPA
Using eye drops that contain CRPA can cause serious health issues to develop, including eye infections.
Eye infections caused by CRPA may result in:
- Conjunctivitis (pink eye)
- Endophthalmitis (inflammation of intraocular fluids)
- Keratitis (inflammation of the cornea)
- Pain or vision loss
- Other infections
- Death
If you or a loved one experienced any of these health issues after using Delsam or EzriCare Artificial Tears, you may be able to file an EzriCare lawsuit and pursue compensation.
Contact Simmons Hanly Conroy now to learn more about your options for free.
Who Can File a Delsam or EzriCare Lawsuit?
Generally speaking, you may be eligible to file a Delsam or EzriCare lawsuit if you or a loved one:
- Used Delsam or EzriCare Artificial Tears Lubricant Eye Drops or Ointment
- Experienced vision loss or developed an infection afterward
Find out if you have a qualifying case now by contacting our team. It costs nothing to speak with us.
Filing an EzriCare Eye Infection Lawsuit
At Simmons Hanly Conroy, we know what you’re going through now may be extremely difficult, even before you factor in the legal deadlines and paperwork associated with filing a claim — so let us take care of the legal work for you.
If you have a case, our team can handle every step of the legal process for you, so you can focus on your health and recovery.
This process may involve your EzriCare lawyers and legal team:
- Gathering evidence like medical records and testimony to prove your claim
- Filing the Delsam or EzriCare Artificial Tears lawsuit on your behalf within any deadlines or statutes of limitations
- Negotiating an EzriCare vision loss settlement with the manufacturer if possible
- Going to court to present your case in trial before a judge or jury
Our experienced lawyers work on a contingency basis, which means there are no out-of-pocket or hourly costs to work with us. We only get paid if your case results in compensation, so there’s no financial risk to taking legal action.
Get Help with Your EzriCare Artificial Tears Lawsuit
At Simmons Hanly Conroy, we’re proud to help clients across the country stand up to the companies that harmed them and get compensation for the injuries they suffered.
Why choose Simmons Hanly Conroy for your EzriCare Artificial Tears claim?
- Over 20 Years of Experience: Since 1999, Simmons Hanly Conroy has helped provide thousands of injured clients with a powerful voice in the legal system.
- Legal Help Nationwide: Simmons Hanly Conroy is a national law firm, with offices and attorneys across the country. Regardless of where you may be in the U.S., our EzriCare lawyers are here to help.
- No Out-of-Pocket Costs: We only get paid if we’re able to recover compensation in your case. There are no upfront costs or hourly fees.
- A Track Record of Results: Our firm has recovered over $10.1 billion across all types of cases we handle, which include a variety of dangerous drugs and devices.
Ready to get started? Contact our team now. We can let you know if you have a case for free and provide more information about your next steps.
EzriCare Eye Infection Lawsuit FAQs
How long do I have to file an EzriCare or Delsam lawsuit?
You only have a limited amount of time, known as statutes of limitations, to file an EzriCare or Delsam lawsuit for vision loss or eye infections. This time frame varies from state to state.
Once the statute of limitations passes, however, you will not be able to file a Delsam or EzriCare Artificial Tears lawsuit or pursue compensation for your injuries.
Contact our team now if you or a loved one used these products and later developed an infection, experienced vision loss, or passed away as a result.
Have EzriCare Artificial Tears been recalled?
Yes. Global Pharma, the manufacturer of Delsam and EzriCare Artificial Tears and Ointment, issued a voluntary recall of the eye drops at the suggestion of the U.S Food & Drug Administration (FDA).
This product was recalled due to potential contamination after the Centers for Disease Control and Prevention (CDC) identified 68 patients with bacterial infections caused by the eye drops.
Eye drops that may be contaminated with CRPA are labeled with the following product codes:
- Ezricare NDC 79503-0101-15, UPC 3 79503 10115 7
- Delsam Pharma’s NDC 72570-121-15, UPC 3 72570 12115 8
Get help filing a Delsam and EzriCare recall lawsuit. Contact Simmons Hanly Conroy now.
Start My Free Consultation
Start My Free ConsultationSecure Submission
Reviewed by:Laurence Valere Nassif- Fact-Checked
- Legal Reviewer
With over 15 years of legal experience, Larry has secured millions of dollars on behalf of his clients and tried several cases to verdict. In 2007, he was a member of the trial team that achieved a $47.5 million verdict in Humeston v. Merck & Co. on behalf of patients who suffered cardiovascular injuries as a result of taking Vioxx. In 2003, he also helped secure a $2 million verdict on behalf of his client who suffered from Rezulin-related liver damage. He has also helped families impacted by mesothelioma and other asbestos-related diseases from around the country.